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Major role in the pathogenesis of the changes development in the heart tissue due
to anoxia during myocardial infarction play activated polymorphonuclear leukocytes. Under
conditions of hypoxia activated neutrophils are generating oxygen free radicals and releas
ing the contents of their granules with a number of lysosomal enzymes. There are very
interesting to have different possibilities of pharmacological regulation of this kind of pa
thology of a high activated neutrophils. For example, stimulation of adenylate cyclase by
prostaglandin E2 (PGE2) in neutrophils can leads to an increase of intracellular cAMP levels
in neutrophils, and then to reduction of leukotrienes formation and to reduction of the in
flammatory processes degree.
The use of compounds in pharmacotherapy, which are inhibitors of the enzyme phos
phodiesterase (cAMP degrading enzyme) can also enhance the effect of elevated concen
tration of cAMP and thus leads to suppression in the activation processes of neutrophils
and also platelets. The compounds, which can inhibit the process formation from arachi
donic acid (AA) some active metabolites by activated neutrophils, are also important during
heart ischemia. Moreover, we have known a synergistic effect between stimulators of c
AMP and cGMP (by EDRF/NO) in the white blood cells and platelets. Endogenous EDRF/
NO is synthesized from the aminoacid Larginine by the enzyme NOsyntase, mainly in the
vascular endothelium as well as in other cells. NO is constitutively secreted by endothelial
cells but its production is modulated by a number of exogenous chemical and physical
stimuli, whereas the other known mediators (PGI2, Endothelin1 and PAF) are synthesized
primarily in response to changes in the external environment. Both endogenous and exog
enous NO (liberated from NOdonors) may bind to the heme enzyme  guanylate cyclase.
This effect is stimulated by guanylate cyclase and then followed by the increase of the c
GMP production in the cells. Reduction of endogenous NO formation in the absence of
substitution, lead to a number of causes pathological changes in a front of acceleration of
aterothrombosis process, higher activation of platelets and more opportunities for their
adhesion and aggregation particularly in ischemic and hypoxic conditions, the shrinkage of
blood vessels, reducing the blood flow through the coronary arteries, and in the case of
beginning myocardial infarction to extend the zone of ischemia and necrosis of hemody
namic consequences. Reduced endogenous production of NO and thus the deficiency
occurs in conditions of excessive production and release of active vasoconstriction com
pounds (leukotrienes, in front of leukotriene B4 as well as thromboxane A2 and endothelin
1) deepens further reduced vascular flow, leading to coronary artery spasm. Pharmacolog
ical ability to regulate the biosynthesis of endogenous NO with elevation of NO level in cells
in various stages of pathological condition because of heart ischemia can be also conduct
ed by NOdonors a compounds that can release from their structure egzogenous nitric
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Septic and aseptic inflammation proc;
esses in the tissues are accompanied by
accumulation and activation of polymorpho;
nuclear leukocytes, neutrophils. These cells
are able to adhere to the blood vessel wall,
migrate through the vessel wall and the
destruction of not only microorganisms, but
also its own tissues, which have been dam;
aged or changed by ischemia and /or influ;
encing inflammatory processes by immuno;
logical processes [1, 2]. An example of
aseptic inflammation that runs from the
activation of neutrophils, activated with the
action of main mechanisms of humoral and
cell;mediated immunity is a ischemic area
of myocardial infarction. Major role in the
pathogenesis of the development of these
changes in the heart tissue due to anoxia
during myocardial infarct seem to play just
activated polymorphonuclear leukocytes,
and also other types of leukocytes. These
cells are involved in the destruction of dam;
aged and dead tissue, and in the prepara;
tion of repair processes leading to the for;
mation of scar tissue, also modulate repair
processes. Migration of neutrophils takes
place in the first hours of ischemia and then
also through the vascular endothelium and
is largely associated with the activation of
the components of complement system
appearing in a relatively high concentration
of highly active immune component C3 and
C5a complement, which show strong chem;
otactic and chemokinetic activity. Activated
complement components, especially C5a,
have a strong activating effect for neu;
trophils. This leads to an increase in adhe;
sion of neutrophils to vascular endothelium,
and the appearance of granulocytes aggre;
gation, and then to increase the peripheral
resistance and in consequence decrease of
blood flow in the ischemic area of myocar;
dial tissue [1, 2, 3]. The role of neutrophils
in the process of myocardial ischemia is
associated not only with the mechanical
disturbances due to the appearance in the
circulation of the neutrofils circulating ag;
gregates and their adhesion to endothelial
cells. Activation of neutrophils, due primari;
ly to the component of the complement
C5a, which causes the increase of glucose
metabolism, mainly in pentose cycle alter;
nating circuit, with simultaneous increase in
the consumption of oxygen, which is re;
ferred to as “oxygen burst” [1]. This proc;
ess is accompanied by activation of an en;
zyme catalyzing the production of complex
molecules of oxygen and simultaneous ox;
idation of NADPH oxidase localized in the
cell membrane and the formation of highly
biologically reactive superoxide anions O
2
;,
then under the influence of the enzyme
superoxide dismutase (SOD) they are con;
verted to hydrogen peroxide (H
2
O
2
). Super;
oxide anions are converted by the enzyme
myeloperoksydase in the presence of Cl; ,
Br; and other highly reactive compounds
such as hypochlorous acid (HOCl), hypobr;
omous acid (HOBr), which in the presence
of water are decomposed to release singlet
oxygen 1O
2
 molecule [1, 2, 4, 5].
Discovered in 1980 nitric oxide EDRF/
NO by Furchgott and Zawadzki, a strong
vasodilatatory factor, that is produced and
released by the vascular endothelium, was
originally named as Endothelium Derived
Relaxing Factor (EDRF) [6]. It is a vasodila;
tor, modulating vascular tone, blood pres;
sure and hemodynamics, a important role
for angina, heart failure, pulmonary hyper;
oxide (NO). Moreover, negative effects of oxygen free radicals overgeneration by activated
polynuclear granulocytes during ischemia and hypoxia condition can be regulated by free
radicals scavengers. The knowledge of different mechanisms with pathologic consequenc;
es activation of neutrophils during aseptic inflammation caused by ischemia and hypoxia
as well as these processes possibility of pharmacological regulation are necessary to prop;
er introduce and effective conduction of optimal pharmacotherapy of cardiovascular pa;
thology caused by ischemia and hypoxia.
Key words: hypoxia, septic and aseptic inflammation processes, neutrophils, free oxygen
radicals, lysosomal enzymes, endothelium, nitric oxide (NO), NOsynthase, NOdonors.
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tension and also erectile dysfunction. In
addition, its powerful antioxidant, anti;in;
flammatory and antithrombotic actions are
antiatherogenic with antiatherothrombotic
activity [6]. NO is synthesized from the
amino acid L;arginine by the enzyme NO;
syntase, mainly in the vascular endothelium
as well as in other cells. L;arginine due to
oxidative dezimination is converted to the
final product ; NO and L;citrulline, but one
of the intermediate product is N;hydroxy;L;
arginine. NO is constitutively secreted by
endothelial cells but its production is modu;
lated by a number of exogenous chemical
and physical stimuli, whereas the other
known mediators (PGI2, Endothelin;1 and
PAF) are synthesized primarily in response
to changes in the external environment [7,
8]. In the process of NO production may
interfere with acting as a brake ; the so;
called inhibitors of the biosynthesis of en;
dogenous NO. These are false substrates
for the enzyme ; NO synthase. These com;
pounds can include, among others NG;
monomethyl;L;arginine NG;mononitro;L;
arginine. These inhibitors of endogenic NO
biosynthesis compounds can significantly
increasing systemic vascular resistance with
subsequent increased blood pressure, in;
cluding also pathological conditions related
with increased production of nitric oxide /
NO/ (for example overproduction of NO in
septic shock). For impaired NO formation
occurs in the process of atherogenesis,
which has important clinical consequences,
mainly concerning the cardiovascular sys;
tem and also immune system. NO also plays
a important regulatory role in the central and
peripheral nervous system. Decreased NO
level leads to vasoconstriction with higher
permeability and even more deeper tissue
hypoxia with simultaneous stimulation of
platelets to adhesion and aggregation [7, 8].
Activated neutrophils under conditions
of hypoxia in addition to generating oxygen
free radicals, release the contents of their
granules, ie, allowing a number of lysosom;
al enzymes dissolve, then absorb the re;
vised antigenic tissue. Among these may be
mentioned enzymes such as elastase, acid
hydrolases (such as beta;glucuronidase),
myeloperoxydase, and others enzymes [1,
2, 4, 5]. Neutrophil activation also leads to
increased synthesis and release of phar;
macologically very active metabolites of
arachidonic acid, mainly products of lipoox;
ygenation. Under the influence of 5;lipoxy;
genase from arachidonic acid (AA) are gen;
erating leukotrienes, particularly leukotriene
B4. That has a very potent chemotactic and
chemokinetic action for neutrophils and has
the capacity to ability longer stimulation
neutrophils to generation of O
2
; anion, and
production of leukotrienes C4 and D4, a
strong contracting substances for vascular
smooth muscle as well as the production of
thromboxane A2 (TXA2) from arachidonic
acid (AA) by cyclooxygenase. Thromboxane
A2 rapidly activate platelets to aggregation
and also constrict of vascular smooth mus;
cles Lysosomal enzymes, oxygen free rad;
icals and active metabolites of arachidonic
acid (leukotrienes) released from activated
neutrophils sharing in the processes of re;
moving dead tissue but also acts destruc;
tive to healthy surrounding tissue, so they
can expand the zone of ischemia, for exam;
ple myocardial infarction zone [1, 5, 7, 8, 9].
There are different possibilities of
pharmacological inhibition of stimulated
neutrophils excessively, which can deter;
mine the degree of ischemic injury and
myocardial tissue with insufficient oxygen.
Ischemia and myocardial anoxia leads to the
formation of aseptic inflammation primarily
goes from activation of platelets and poly;
morphonuclear granulocytes, neutrophils,
their adhesion to the vascular endothelial
cells and aggregation [10]. These process;
es intensify of ischemic hypoxic zone of
myocardial area largely by activating com;
ponents of the complement (C5a mostly),
which have a strong chemotactic and chem;
okinetic activity. Neutrophil activation leads
to an increase in the intracellular concen;
tration of calcium ions, to form highly reac;
tive oxygen free radicals (superoxide anions
mainly O
2
; and also hydroxyl radicals, sin;
glet oxygen and hypochlorous acid, which
are destructive factors for act on the sur;
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rounding cells and tissues, for endothelial
damage and myocardial tissue during inf;
arction. All these processes lead to a deep;
er ischemic area to the surrounding tissue
edema, increased permeability of blood
vessels and can lead to induction of arrhyth;
mias. Generation of hydroxyl radicals, which
inactivate the enzyme prostacyclin syn;
thase, leading in this condition to a reduc;
tion in endogenous production of prostacy;
clin PGI2. Moreover, the reduction produc;
tion and inactivation of nitric oxide ; NO also
leads to increased platelet activation and
increases contraction of coronary vessels.
The changes of concentration of free calci;
um ions plays important role in the process
of neutrophils activation [1, 7, 8, 9, 10]. The
rapid increase in the concentration of free
calcium ions leading to the activation of
these cells and are as strong activating fac;
tor for regulation activity of the enzyme 5;
lipoxygenase, which is required to activate
a higher concentration of free calcium ions
than cyclooxygenase. Pharmacological
compounds which may reduce intracellular
free calcium ions concentration, thereby
may reducing the activity of the enzyme 5;
lipoxygenase and arachidonic acid as well
as process of lipooxygenation and thus re;
duce the production of leukotriene B4, C4
and D4 by activated neutrophils [1, 5, 9].
The process of neutrophil activation may
play an important role in changing the con;
centration of cyclic nucleotides: cAMP and
cGMP, increase in the cells concentration of
these cyclic nucleotide leads to a reduction
in the bioavailability of free calcium ions and
thus to inhibition of the 5;lipooksygenation
activity, leading to decrease leukotrienes
production by activated neutrophils. Similar
effects are found in platelets, where an in;
crease in the concentration of cAMP and
cGMP reduces and inhibits their activation.
In effects of these process we can see su;
pression of platelets adhesion and aggre;
gation [7, 8]. In the case stimulation of
adenylate cyclase by prostaglandin E2
(PGE2) in neutrophil, it leads to an increase
in intracellular cAMP levels in neutrophils,
then to reduction of leukotriene formation
as well as to reduction degee of inflamma;
tory processes. On the other hand, the use
of compounds in pharmacotherapy, which
are inhibitors of the enzyme phosphodieste;
rase (cAMP degrading enzyme) enhances
the effect of cAMP and thus leads to sup;
pression in the activation processes of neu;
trophils and platelets. Pharmacologically
active compounds that are released from
their structure egzogenic nitric oxide (NO):
“NO;donors” (eg, the active metabolite of
molsidomine: SIN;1), stimulates the enzyme
guanylate cyclase and in consequence ele;
vate production of cGMP in these cells. A
synergistic effect between stimulators of c;
AMP and c;GMP in the white cells and plate;
lets and compounds which can inhibit of
proces formation of arachidonic acid active
metabolites by activated neutrophils are also
important in condition of heart ischemia [7,
8, 10, 11].
Oxygen free radicals generated by
activated polymorphonuclear granulocytes
in hypoxia condition, or by the fact that
oxygenated blood flow during coronary ar;
tery reperfusion by pharmacological or in;
vasive method, can be inactivated by the
enzyme superoxide dismutase (SOD), glu;
tathione peroxidase or by catalase. Ability
of scavenging oxygen free radicals also have
a coenzyme Q, tocopherols, and also man;
nitol [2, 5, 11]. Damage to cells of ischemic
area caused by reperfusion is associated
also with an increase in intracellular calci;
um ions. In this case may be important
question, whether calcium channel blockers
can be valuable preparations used to reduce
the extent of ischemic damage to the area
due to myocardial infarction, also caused by
reperfusion. The importance of this group
of drugs is limited. Although they increase
the tolerance to ischemia, but only if it is
given before the onset of ischemia, further;
more they do not limit infarct size, and they
can influence the dynamics of reducing the
ischemic area caused by myocardial infarc;
tion. Taking into account that they may lead
to reduction of neutrophils activation, calci;
um antagonists may be useful in treating
and reducing the effects of ischemia and
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hypoxia caused by myocardial infarction. Of
course, always be aware of their negative
ino;and tonotropic action of calcium antag;
onists, which is crucial for them in the event
of heart failure during myocardial infarction,
low cardiac output as well as in cardiogenic
shock [1, 5, 10, 11, 12].
Several known several types of the
enzyme ; NO synthase, which is dependent
on NADPH. Constitutively NO synthasis,
which occurs primarily in endothelial cells
and nerve cells, is dependent on Ca2+ ions
and the calmodulin. It is activated by an
increase in intracellular calcium ion concen;
tration, which is an increase in the endothe;
lium cells is caused by mediators such as
acetylcholine, bradykinin, histamine. The
factor that causes nerve cells constitutively
activated forms of NO synthase and the
subsequent rise of endogenous NO produc;
tion, an increase in the concentration of
calcium ions caused by nerve impulse. From
the constitutive NO synthase activity is de;
pendent vascular wall tension or vascular
resistance and blood pressure. Inducible
form of NO synthase is independent of cal;
cium and calmodulin. It is absent in non;
activating macrophages and its activity ap;
pears only after activation of these cells or
bacterial lipopolysaccharides, certain cy;
tokines such as interleukin;1 beta or TNF;
alpha (tumor necrosis factor). This creates
a form;synthase endogenous NO as long as
long as it is accessible to the substrate (ie,
L;arginine). Induction of this form of the
enzyme may also occur in the vascular
smooth muscle cells and be controlled by
interleukokin 8, TGF beta or by platelet de;
rived growth factor (PDGF). Constitutive and
inducible form of NO synthesis, it flawopro;
tein containing adenine mononucleotide
FMN and FAD, is dependent on tetrahydro;
biopterin (TH4). TH4 determine the activity
of these enzymes, NO synthase. Both en;
dogenous and exogenous NO may to bind
to the heme enzyme ; guanylate cyclase.
The effect of this action is stimulation of
guanylate cyclase and then increase the
production of c;GMP in the cells. NO can
simultaneously connect to various other
enzymes containing ;SH groups, resulting
in a block and the inactivation of these en;
zymes. Intracellular growth of c;GMP con;
centration causes vasodilation (the vasodi;
latatory effect) and reduces the over;activ;
ity of activated platelets, and consequently
reducing their mobilization for adhesion and
aggregation, and the participation of acti;
vated neutrophils in inflammatory process;
es, including under aseptic conditions in;
flammation caused by ischemia and hypox;
ia. NO is rapidly destroyed by free radicals,
anions O
2
;. The reaction of NO with O
2
 an;
ions can form highly reactive and toxic free
radical ONOO;,  which is a potent destruc;
tive not for foreign bacteria and other organ;
isms that can cause inflammation, but also
cause damage to other cells and tissues.
Potential mechanism of cytotoxicity pro;
duced in excess and liberated nitric oxide
NO and NO released by the exogenous
chemical compounds (drugs: “NO donors”),
which is associated with the nitrosylation by
NO nucleic acids. Excessive nitrosylation
may however lead to malignant transforma;
tion of cells. So after prolonged use of ni;
trates, NO;releasing drugs with cardiac in;
dications should be kept in mind. Excessive
formation and release of endogenous NO,
and NO is supplied exogenously, can be so
harmful [6, 7, 8, 10, 13]. Nitric oxide (NO)
is generated in a variety of cells but and
particularly in the endothelium and is an
endogenous compound. Reduction of en;
dogenous NO formation in the absence of
substitution, lead to a number of causes
pathological changes in a front of acceler;
ation of aterothrombosis process, higher
activation of platelets and more opportuni;
ties for their adhesion and aggregation par;
ticularly in ischemic and hypoxic conditions,
the shrinkage of blood vessels, reducing the
flow blood through the coronary arteries,
and in the case of beginning myocardial
infarction to extend the zone of ischemia
and necrosis of hemodynamic consequenc;
es [10, 14, 15]. In this situation, reduced
endogenous production of NO and thus the
deficiency occurs in conditions of excessive
production and release of active vasocon;
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striction compounds (leukotrienes, in a front
of leukotriene B4 as well as thromboxane A2
and endothelin;1) deepens further reduced
vascular flow, leading to coronary artery
spasm, to expand infarct zone as well as to
a number of others important consequenc;
es extracardiac, such as changes in blood
pressure and reduction of renal perfusion.
Increase the effects of NO is possible by
pharmacological intervention in the process
of endogenous NO (eg, the substrate L;ar;
ginine), and reducing the rate of decompo;
sition of NO (eg, drugs that inhibit the en;
zyme activity phosfodiaeterase;type5
(PDE5)) and most and, above all, by the
substitution of exogenous NO. Increased
production of endogenous NO can be
achieved by providing a substrate for
parenteral its formation, ie, the above;men;
tioned L;arginine, also activating the NO
synthase addition, some compounds with
antioxidant activity, which may prolong the
operating time has already produced NO. In
most clinical circumstances increases the
NO concentration in the body giving the
compounds having a built;in part of its
structure in the form of NO, drugs NO;re;
leasing directly or such drugs which metab;
olized after release NO. The most important
“NO donors” include nitroglicerine (NTG),
SIN;1 ; the active metabolite of molsidom;
ine and also sodium nitroprusside. Conven;
tional nitrates using in pharmacotherapy are:
glyceryl trinitrate (nitroglycerin, NTG),
izosorbitolu dinitrate and mononitrate sorb;
itol. The mechanism of action of nitrates is
associated with the presence of a group of
NO3 which enzymatically in the presence of
reduced glutathione (GSH) is reduced in the
smooth muscle cells of the heart and to a
highly active nitrogen oxide /NO/. The ef;
fectiveness of nitroglycerin and other ni;
trates containing NO3 group, depends on
adequate stocks reduced GSH in smooth
muscle cells and heart. In case of reduction
of GSH occurs so nitrates tolerance and if it
is necessary to increase the dose to achieve
a similar clinical effect. Tolerance to nitrates
can be stopped with eg. N;acetylcysteine,
which increases the number of reduced
GSH. Molsidomine is a compound from the
chemical group of sydnoimine, that only
metabolised in the liver, where it is convert;
ed to its active metabolite ; SIN;1 and SIN;
1A, and can only this structure directly re;
lease NO. Nitric oxide can be very quickly
released immediately after parenteral ad;
ministration of sodium nitroprusside, which
is sometimes, but very rarelly can be used
to rapidly reduce the pressure in clinical
situations which require very rapid pharma;
cological intervention. The knowledge of
nitric oxide /NO/ biological properties in the
field of its regulatory role in maintaining the
homeostasis of the organism is very impor;
tant for treatment of several diseases. Phar;
macological ability to regulate the biosyn;
thesis of endogenous NO and in conse;
quence NO level in cells in various stages
are useful for the treatment of a lot of path;
ological conditions of deficiency of endog;
enous NO or excess of NO production [7,
8, 10, 11, 14, 15].
Understanding mechanisms of pathol;
ogy, roles and negative effects of oxygen
free radicals overgeneration by activated
polymorphonuclear granulocytes in
ischemia and hypoxia condition with action
of liberated a number of lysosomal enzymes
and autocoids because of aseptic inflamma;
tion caused by ischemia and hypoxia as well
as knowledge action and effects of nitric
oxide /NO/ in many pathological conditions
of the cardiovascular system are necessary
to proper introduce and effective conduc;
tion of optimal pharmacotherapy of cardio;
vascular pathology because of ischemia and
hypoxia.
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Резюме
РЕЗУЛЬТАТЫ АКТИВАЦИИ
НЕЙТРОФИЛОВ ПРИ ИШЕМИИ И
СЕРДЕЧНО;СОСУДИСТЫХ
ЗАБОЛЕВАНИЯХ, РОЛЬ ОКСИДА АЗОТА
(NO) И ФАРМАКОЛОГИЧЕСКИЕ
СПОСОБЫ РЕГУЛИРОВАНИЯ
Рутовски Я.А.
Показаны механизмы патологии,
роль и негативные последствия повы;
шенной генерации свободных радикалов
кислорода активированными полимор;
фоядерными гранулоцитами при ишеми;
ческом и гипоксичном состояниях, изме;
нения, вызванные высвобождением ряда
лизосомальных ферментов из;за асепти;
ческого воспаления, вызванного ишеми;
ей и гипоксией. Рассмотрены влияние и
механизм действия оксида азота на фоне
ряда патологических состояний сердеч;
но;сосудистой системы.
Ключевые слова: гипоксия, септичес
кие и асептические воспалительные
процессы, нейтрофилы, свободные
кислородные радикалы, лизосомаль
ные ферменты, эндотелий, оксид азота
(NO), NOсинтаза, NOдоноры.
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Резюме
РЕЗУЛЬТАТИ АКТИВАЦІЇ НЕЙТРОФІЛІВ
ПРИ ІШЕМІЇ ТА СЕРЦЕВО;СУДИННИХ
ЗАХВОРЮВАННЯХ, РОЛЬ ОКСИДУ
АЗОТУ (NO) І ФАРМАКОЛОГІЧНІ
СПОСОБИ РЕГУЛЮВАННЯ
Рутовський Я.А.
Показано механізми патології, роль
і негативні наслідки підвищеної генерації
вільних радикалів кисню активованими
поліморфоядернимі гранулоцитами при
ішемічному і гипоксічному станах, зміни,
викликані вивільненням ряду лізосомаль;
них ферментів через асептичного запа;
лення при ішемії та гіпоксією. Розглянуто
вплив і механізм дії оксиду азоту на тлі
низки патологічних станів серцево;судин;
ної системи.
Ключові слова: гіпоксія, септичні та
асептичні запальні процеси, нейтрофі
ли, вільні кисневі радикали, лізосо
мальні ферменти, ендотелій, оксид
азоту (NO), NOсинтаза, NOдонори.
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В даний час в Україні є тенденція до
збільшення кількості хворих, які зловжи;
вають психоактивними речовинами. Од;
нією з проблем сучасної медицини є
збільшення частоти гострих психозів у
хворих із залежністю від психоактивних
речовин, найчастіше вони розвиваються
в стані відміни від вживання алкоголю під
час лікування з приводу різних соматич;
них захворювань, черепно;мозкових
травм і т.д. [10].
Стан відміни з делірієм та психо;
тичні розлади внаслідок вживання алко;
голю займають одне з перших місць се;
ред гострих екзогенних психозів, що ви;
магають інтенсивної терапії. Історична
практика показує, що в умовах економіч;
ної та соціальної нестабільності зростан;
ня захворюваності білою гарячкою прий;
має епідемічні масштаби. На підставі су;
часних даних алкогольні делірії за смерт;
ністю (20% випадків при відсутності ліку;
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ВИКОРИСТАННЯ АНАЛІЗУ ВАРІАБЕЛЬНОСТІ СЕРЦЕВОГО
РИТМУ ДЛЯ ОЦІНКИ СТАНУ ВЕГЕТАТИВНОЇ ДИСФУНКЦІЇ У
ПАЦІЄНТІВ ІЗ СТАНОМ ВІДМІНИ ВНАСЛІДОК ВЖИВАННЯ
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У статті наведені результати досліджень щодо використання методу оцінки ва;
ріабельності серцевого ритму у пацієнтів із алкогольним абстинентним синдромом без
деліріозного синдрому в умовах реанімаційного відділення. Дослідження проводили;
ся в перший день госпіталізації пацієнтів у клініку. Отримані дані порівнювалися із
варіантами норми відповідних показників варіабельності серцевого ритму. Отримані
результати свідчать про значну вегетативну дисфункцію в пацієнтів із алкогольним аб;
стинентним синдромом та про наявність кореляційних зв’язків між показниками вар;
іабельності серцевого ритму і показниками гемодинаміки.
Ключові слова: варіабельність серцевого ритму, вегетативна дисфункція, алкоголь
ний абстинентний синдром, стресіндекс Баєвського.
